Postgraduate Course

Merging the Evidence and the Art: The Latest Clinical Practice Updates in Gastroenterology and Hepatology

Course Directors: Christina Y. Ha, MD, FACG, and Colleen R. Kelly, MD, FACG

7:50 am Introduction by Course Directors
Christina Y. Ha, MD, FACG, and Colleen R. Kelly, MD, FACG
8:00 am Session 1A: Colorectal Cancer: Best Practices for Early Recognition and Surveillance
Moderator: Folasade P. May, MD, PhD, MPhil
  • Screening for CRC: Who, What, When, Where and Why?
    Folasade P. May, MD, PhD, MPhil
    Summarize the latest guidelines and best practices for colorectal cancer screening based on individual risk factors. Provide recommendations regarding how to improve community CRC screening rates.
  • A Primer on Polyps: Identification, Description, and Resection
    Tonya R. Kaltenbach, MD, MS, FACG
    Discuss the features that differentiate adenomas, hyperplastic lesions, serrated polyps, and lateral spreading tumors. Discuss the role of enhanced imaging modalities and best practices for endoscopic resection.
  • What Happens Next? Post-Polypectomy Surveillance Recommendations
    Samir Gupta, MD
    Explain the recommendations for surveillance and screening intervals in individuals found to have polyps during colonoscopy based on the number, size, and histology of polyps removed.
  • Quality Indicators in Colonoscopy: It’s All in the Details
    Douglas K. Rex, MD, MACG
    Define the markers of a high-quality colonoscopy including prep quality and withdrawal time. Explain the importance of rating the quality of bowel preparation during colonoscopy and determining interval colonoscopy for patients with inadequate bowel preparation.
  • Panel Q & A
9:40 am Break
10:00 am The David Sun Lecture – The Two Most Important Days: Reflections on Lasting Happiness and Living With Purpose
Sanjiv Chopra, MD
10:30 am Session 1B: Hot Off the Presses: The Latest Liver Updates for Practicing Clinicians
Moderator: Jasmohan S. Bajaj, MD, MSc, FACG
  • Acute-on-Chronic Liver Failure: Updates From the 2022 ACG Guidelines
    Jasmohan S. Bajaj, MD, MSc, FACG
    Summarize the latest recommendations for evaluation and management of patients who present with acute and severe hepatic derangements in the setting of underlying liver disease or cirrhosis.
  • More and Younger Patients: Trends in Alcohol-Associated Liver Disease and Most Effective Treatments
    Vijay H. Shah, MD, FACG
    Explain the role of the gastroenterologist in the diagnosis and multidisciplinary management of alcohol use disorder and alcohol-associated liver disease. Summarize the latest treatment options for ALD.
  • The Rapidly Growing Epidemic of Non-Alcoholic Fatty Liver Disease: What Should We Do?
    A. Sidney Barritt, IV, MD, MSCR, FACG
    Highlight the risk factors and the evidence-based management of nonalcoholic liver disease. Describe the indications and limitations of non-invasive testing and liver biopsy in patients with NAFLD.
  • Does This Patient Need a Liver Biopsy? Utilizing Noninvasive Markers of Fibrosis and When to Pull the Trigger to Get Tissue
    Ayse Aytaman, MD, FACG
    Describe indications and limitations of noninvasive testing and indications for obtaining a liver biopsy in patients with abnormal liver function tests.
  • Panel Q & A
12:10 pm Break for Learning Luncheons
12:20 pm –
1:35 pm
Saturday Learning Luncheons

Separate Purchase Required: You must register for the Postgraduate Course in order to purchase the optional Learning Luncheon Bonus Sessions package. In-person attendees purchasing the package will be able to select a Saturday and a Sunday session during the registration process.

Both in-person and virtual-only attendees will receive access to the faculty presentation slides from ALL 24 Learning Luncheon Bonus Sessions. On-demand Bonus Sessions are pre-recorded narrations by faculty of their presentation slides. These sessions will be available to watch on the ACG 2022 Conference Platform, from late October until March 31, 2023.

  1. What Every Clinician Needs to Know About the Microbiome: Composition, Function and Emerging Live Microbiome Therapeutics
    Paul Feuerstadt, MD, FACG
    Become familiar with common terminology, methodologies used to examine the gut microbiome, composition of function of the gut microbiome and ways microbiome data are communicated in the scientific literature. Discuss the spectrum of products in the pipeline for treatment of recurrent C. difficile and other indications and consider how their approval is likely to change the landscape around FMT.
  2. Master Class: Complex and Challenging Polyps
    Douglas K. Rex, MD, MACG
    Learn expert tips and techniques for endoscopic resection of polyps that are large, flat, difficult to visualize, or otherwise challenging.
  3. Preventing the “Inadequate Bowel Prep” Dilemma: Best Practices and Patient Guidance to Yield a High-Quality Exam
    Audrey H. Calderwood, MD, MS, FACG
    Explain the definition of inadequate bowel preparation and the appropriate interval to repeat colonoscopy procedure in the event of an inadequate bowel preparation.
  4. H. pylori: Rise of the Resistance – Initial and Rescue Regimens
    Colin W. Howden, MD, FACG
    Identify who and how to test for H. pylori, chose best first-line regimens, and discuss the role of antibiotic resistance testing.
  5. Esophageal Physiologic Testing: When to Order it and How to Interpret the Findings
    C. Prakash Gyawali, MD, MRCP, FACG
    Describe the role of performing a reflux monitoring study while on versus off treatment with proton pump inhibitors. Summarize the indications for esophageal manometry and describe classic manometric findings of esophageal disorders such as achalasia.
  6. How I Do It: A Practical Approach to the Diagnosis and Management of Functional Dyspepsia
    Linda Ahn B. Nguyen, MD, FACG
    Understand normal gastric function and recognize the role of both altered motility and altered sensation in patients presenting with functional dyspepsia and describe management strategies that target these differing mechanisms.
  7. Gas and Bloating: Controlling Emissions
    Gregory S. Sayuk, MD, MPH
    Identify an organized approach to the evaluation of symptoms of gas, bloating, and belching, and utilize best empiric therapies.
  8. Quality Indicators in Upper GI Endoscopy
    Sachin B. Wani, MD
    Explain the accepted indications for upper endoscopy and the quality indicators for endoscopy including structural measures, process measures, and outcome measures.
  9. Updates in the Management of Hepatocellular Carcinoma
    Patricia D. Jones, MD, MSCR
    Highlight the risk factors, surveillance and management strategies for hepatocellular carcinoma including patient criteria for liver transplantation.
  10. Optimizing Nutrition in Liver Disease
    Craig J. McClain, MD, FACG
    Highlight the impact of malnutrition and deficiencies in chronic liver disease and strategies to optimize nutritional status to improve patient outcomes.
  11. Updates in Caring for Pregnant Women With Irritable Bowel Syndrome: A Case-Based Approach
    Baharak Moshiree, MD, FACG
    Highlight the key strategies for monitoring and treating irritable bowel syndrome in women throughout pregnancy and post-partum.
  12. Cases From an IBD Center: Managing IBD Patients Beyond Luminal Inflammation
    Anita Afzali, MD, MPH, MHCM, FACG
    Discuss some of the daily challenges and frustrations encountered in caring for patients with inflammatory bowel disease including mental health issues, compliance, communications, managing expectations and medication coverage.
1:35 pm Break
1:45 pm –
3:00 pm
Simultaneous Symposia

Symposium A: Chronic Diarrhea: Can’t Stop, Won’t Stop – Best Practices for Diagnosis and Management
Moderator: Colleen R. Kelly, MD, FACG

  • Microscopic Colitis: Triggers, Treatments, and Tricks of the Trade
    Darrell S. Pardi, MD, MS, FACG
    Summarize the clinical presentation, risk factors, and management of microscopic colitis. Provide strategies to access treatment options for more refractory cases of microscopic colitis.
  • Challenging Cases in C. difficile
    Colleen R. Kelly, MD, FACG
    Explain how to diagnose C. difficile using multi-step testing, recognize symptomatic colonization, and identify how to manage severe/fulminant or complex cases.
  • The Evolving Case: Stepwise Approach to Chronic Diarrhea
    Carl V. Crawford, Jr., MD
    Develop a rational approach for the evaluation of patients with chronic diarrhea and describe indications for expanded testing to rule out more elusive or rarer etiologies.
  • Panel Q & A

Symposium B: The Rapidly Growing Epidemic: Obesity Practice Guidance
Moderator: Reem Z. Sharaiha, MD, MSc

  • Obesity Treatment: Role of the Clinical Gastroenterologist
    Octavia Pickett-Blakely, MD, MHS
    Summarize non-surgical approaches to managing obesity including diet and pharmacological options. Review the pre-procedure or pre-operative assessments for bariatric patients prior to surgery or endoscopic treatments.
  • Bariatric Endoscopy
    Reem Z. Sharaiha, MD, MSc
    Summarize the endoscopic bariatric procedures currently available and those on the horizon. Discuss the appropriate candidates for bariatric endoscopic versus surgical procedures.
  • Managing Postoperative Complications of Bariatric Surgery
    Pichamol Jirapinyo, MD, MPH
    Recognize the anatomy of bariatric surgery, identifying, and treating complications including nutritional deficiencies, marginal ulceration, and endoscopic management of surgical complications.
  • Panel Q & A

Symposium C: Starting at the Top: Esophageal Disorders Made Easy
Moderator: Nicholas J. Shaheen, MD, MPH, MACG

  • Leading Off With Barrett’s: Update on the New ACG Treatment Guidelines
    Nicholas J. Shaheen, MD, MPH, MACG
    Recognize risk factors for GERD that need to be considered when deciding whether a patient should be screened for Barrett’s esophagus. Review the management of non-dysplastic BE including surveillance intervals.
  • Bird Beaks, Botox, and POEMs: Diagnosis and Management of Achalasia
    John E. Pandolfino, MD, MSCI, FACG
    Identify the 3 subtypes of achalasia and summarize the comparative effectiveness of botulinum toxin injection, pneumatic dilation, Heller myotomy, and POEM for the treatment of achalasia.
  • Sorting Out GERD, NERD, and Non-Cardiac Chest Pain
    Rena H. Yadlapati, MD, MSHS, FACG
    Formulate a plan for the evaluation of patients with GERD symptoms that do not respond to treatment with lifestyle management or PPIs, including the role of endoscopy, reflux monitoring studies, impedance, and motility testing.
  • Panel Q & A
3:00 pm Break
3:35 pm Session 1C: Addressing the Challenges of Pancreaticobiliary Diseases
Moderator: Uzma D. Siddiqui, MD, FACG
  • Endoscopic Management of Acute and Chronic Pancreatitis
    Uzma D. Siddiqui, MD, FACG
    Appraise EUS-guided pain management in the setting of chronic pancreatitis and pancreatic cancer, its safety and efficacy. Discuss the indications and pitfalls of EUS-guided drainage of pancreatic fluid collections.
  • An Updated Approach to Pancreatic and Biliary Strictures
    B. Joseph Elmunzer, MD, MSc
    Summarize the differential diagnosis of pancreatic and biliary strictures and appraise the utility of cross-sectional imaging, cholangioscopy, optical advances and endomicroscopy for indeterminate biliary and pancreatic strictures. Describe the management strategies of biliary and pancreatic strictures.
  • Complications of ERCP: How to Identify and Address Them
    Martin L. Freeman, MD, MACG
    Summarize the complications of ERCP including early recognition, diagnosis, and management strategies.
  • Panel Q & A
4:55 pm Take-Home Pearls: What Did We Learn Today?
Christina Y. Ha, MD, FACG, and Colleen R. Kelly, MD, FACG
Review important and practical take-home messages from today’s talks.
5:15 pm Postgraduate Course Adjourns for the Day